RxNorm Semantic Concepts Index - 681
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "681".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 68115 | piroxicam-beta-cyclodextrin | Designated preferred name (PT) | NO | |
| RxCUI: 68115 | piroxicam-beta-cyclodextrin | Full form of descriptor (FN) | NO | |
| RxCUI: 68115 | piroxicam-beta-cyclodextrin | British preferred term (PTGB) | NO | |
| RxCUI: 68115 | piroxicam-beta-cyclodextrin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 6812 | Metacycline-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6812 | Metacycline-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 6812 | Metacycline-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6812 | Metacycline-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 6812 | Metacycline-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 6812 | Metacycline-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 6812 | Metacycline-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 68120 | Macrolide 2'-kinase | Designated preferred name (PT) | NO | |
| RxCUI: 68120 | Macrolide 2'-kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 6813 | Methadone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6813 | Methadone | Designated preferred name (PT) | YES | |
| RxCUI: 6813 | Methadone | Full form of descriptor (FN) | YES | |
| RxCUI: 6813 | Methadone | Designated preferred name (PT) | YES | |
| RxCUI: 6813 | Methadone | Full form of descriptor (FN) | YES | |
| RxCUI: 68139 | Rocuronium | Full form of descriptor (FN) | YES | |
| RxCUI: 68139 | Rocuronium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 68139 | Rocuronium | Designated preferred name (PT) | YES | |
| RxCUI: 68139 | Rocuronium | Full form of descriptor (FN) | YES | |
| RxCUI: 68139 | Rocuronium | Designated preferred name (PT) | YES | |
| RxCUI: 6814 | methadyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 68147 | cetrorelix | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 68147 | cetrorelix | Designated preferred name (PT) | YES | |
| RxCUI: 68147 | cetrorelix | Full form of descriptor (FN) | YES | |
| RxCUI: 68147 | cetrorelix | Designated preferred name (PT) | YES | |
| RxCUI: 68147 | cetrorelix | Full form of descriptor (FN) | YES | |
| RxCUI: 68149 | mycophenolate mofetil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 68149 | mycophenolate mofetil | Designated preferred name (PT) | YES | |
| RxCUI: 68149 | mycophenolate mofetil | Full form of descriptor (FN) | YES | |
| RxCUI: 6816 | Metamfetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6816 | Metamfetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6816 | Metamfetamine | Full form of descriptor (FN) | YES | |
| RxCUI: 6816 | Metamfetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6816 | Metamfetamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6816 | Metamfetamine | Designated preferred name (PT) | YES | |
| RxCUI: 6816 | Metamfetamine | Designated preferred name (PT) | YES | |
| RxCUI: 6816 | Metamfetamine | Full form of descriptor (FN) | YES | |
| RxCUI: 6817 | Methandriol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 6817 | Methandriol | Designated preferred name (PT) | NO | |
| RxCUI: 6817 | Methandriol | Full form of descriptor (FN) | NO | |
| RxCUI: 6817 | Methandriol | Designated preferred name (PT) | NO | |
| RxCUI: 6817 | Methandriol | Full form of descriptor (FN) | NO | |
| RxCUI: 68173 | Meglumine gadobenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 68173 | Meglumine gadobenate | Designated preferred name (PT) | YES | |
| RxCUI: 68173 | Meglumine gadobenate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 68173 | Meglumine gadobenate | Full form of descriptor (FN) | YES | |
| RxCUI: 68178 | Biapenem | Designated preferred name (PT) | NO | |
| RxCUI: 68178 | Biapenem | Full form of descriptor (FN) | NO | |
| RxCUI: 6818 | Metandienone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6818 | Metandienone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6818 | Metandienone-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 6818 | Metandienone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 6818 | Metandienone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 6818 | Metandienone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 6818 | Metandienone-containing product | Full form of descriptor (FN) | NO |